Kawasaki-Inomata Hiroko, Tabuchi Maiko, Norimatsu Kiyuu, Honda Tetsuro, Matsuda Katsuya, Hashiguchi Keiichi, Yamaguchi Naoyuki, Nishi Hideaki, Kumai Yoshihiko, Nakashima Masahiro, Miyaaki Hisamitsu, Nakao Kazuhiko, Akazawa Yuko
Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8501, Japan.
Department of Histology and Cell Biology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan.
Cancers (Basel). 2024 Aug 28;16(17):2987. doi: 10.3390/cancers16172987.
The DNA damage response protein p53-binding protein 1 (53BP1) accumulates and forms foci at double-strand DNA breaks, indicating the extent of DNA instability. However, the potential role of 53BP1 as a molecular biomarker for hypopharyngeal squamous cell carcinoma (HPSCC) diagnosis remains unknown. Here, we evaluated the potential of immunofluorescence-based analysis of 53BP1 expression to differentiate the histology of hypopharyngeal neoplasms. A total of 125 lesions from 39 surgically or endoscopically resected specimens from patients with HPSCC was histologically evaluated. 53BP1 expression in the nucleus was examined using immunofluorescence. The number of 53BP1 nuclear foci increased with the progression from non-tumorous to low-grade dysplasia, high-grade dysplasia, and squamous cell carcinoma. Unstable 53BP1 expression served as an independent factor for distinguishing lesions that required intervention. Colocalization of 53BP1 foci in proliferating cells, as assessed by Ki67, was increased in tumors ≥ 1000 µm in depth compared to those <1000 µm in depth at the tumor surface. Hence, the expression patterns of nuclear 53BP1 foci were associated with the progression of hypopharyngeal neoplasms. These findings suggest that 53BP1 could serve as an ancillary marker to support histological diagnosis and predict the factors that influence prognosis in patients with HPSCC.
DNA损伤反应蛋白p53结合蛋白1(53BP1)在双链DNA断裂处积累并形成病灶,提示DNA不稳定的程度。然而,53BP1作为下咽鳞状细胞癌(HPSCC)诊断分子生物标志物的潜在作用尚不清楚。在此,我们评估了基于免疫荧光分析53BP1表达以鉴别下咽肿瘤组织学的潜力。对39例经手术或内镜切除的HPSCC患者标本中的125个病变进行了组织学评估。采用免疫荧光法检测细胞核中53BP1的表达。随着病变从非肿瘤性发展为低度异型增生、高度异型增生和鳞状细胞癌,53BP1核病灶数量增加。不稳定的53BP1表达是区分需要干预病变的独立因素。与肿瘤表面深度<1000 µm的肿瘤相比,深度≥1000 µm的肿瘤中,通过Ki67评估的增殖细胞中53BP1病灶的共定位增加。因此,核53BP1病灶的表达模式与下咽肿瘤的进展相关。这些发现表明,53BP1可作为辅助标志物,支持HPSCC患者的组织学诊断并预测影响预后的因素。